文献速递血液净化与透析肾血管病与高血压

植入式循环记录仪监测血液透析患者既往未识别心房颤动的发生率

Implantable Loop Recorder Monitoring and the Incidence of Previously Unrecognized Atrial Fibrillation in Patients on Hemodialysis.
PubMed 文献 · Kidney Int Rep · 2021-10-16

本研究纳入66例血液透析的肾衰竭患者并植入循环记录仪,监测6个月。59例既往未诊断心房颤动者中18例(31%)检出持续≥6分钟的心房颤动,7例既往已诊断者中5例(71%)检出。透析液钙更高与心房颤动风险降低相关,透析液碳酸氢盐更高与风险升高相关。

要点

  • 血液透析的肾衰竭患者中,既往未诊断心房颤动者经循环记录仪监测6个月,31%(18/59)检出持续≥6分钟的心房颤动。
  • 23例检出心房颤动的患者中,心房颤动出现在16%的患者日,多数患者心房颤动负荷较低。
  • 透析液钙>2.5 vs 2.5 mEq/l的房颤发生率比为0.62(95%CI 0.48-0.80);透析液碳酸氢盐>35 vs 35 mEq/l为3.18(95%CI 1.13-8.94)。

核心结论

  • 血液透析的肾衰竭患者中约三分之一检出既往未诊断的心房颤动,心房颤动累及相当比例的患者日,可能是该人群卒中未被充分认识的原因。

研究设计与样本

  • 纳入66例血液透析的肾衰竭患者并植入循环记录仪,在6个月监测期内捕获持续≥6分钟的心房颤动事件。
  • 收集人口学、临床和透析特征,采用负二项回归模型估计与心房颤动发生的关联,以发生率比和95%CI表示。

主要发现

  • 66例患者平均年龄56岁,70%为男性;59例(90%)既往未诊断心房颤动。
  • 59例既往未诊断心房颤动者中18例(31%)检出持续≥6分钟的心房颤动,7例既往已诊断者中5例(71%)检出。
  • 23例检出心房颤动的患者中,心房颤动出现在16%的患者日;14例(61%)心房颤动日占监测日<5%,13例(52%)心房颤动平均持续时间<1小时。
  • 23例心房颤动≥6分钟的患者中,19例(83%)CHA2DS2-VASc评分≥2。
  • 透析液钙>2.5 vs 2.5 mEq/l与心房颤动风险降低相关(发生率比=0.62;95%CI 0.48-0.80),透析液碳酸氢盐>35 vs 35 mEq/l与心房颤动风险升高相关(发生率比=3.18;95%CI 1.13-8.94)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Atrial fibrillation (AF) is common in patients with kidney failure on hemodialysis (KF-HD). We determined both AF incidence and burden in patients with KF-HD using implantable loop recorder (ILR) monitoring. METHODS: Patients with KF-HD were enrolled and received an ILR. In 6 monitoring months, the incidence of AF events lasting ≥6 minutes was captured. Demographic, clinical, and dialysis characteristics were collected, and associations with incident AF were estimated using negative binomial regression models and expressed as incidence rate ratios and 95% CIs. RESULTS: We enrolled 66 patients with KF-HD (mean age = 56 years, 70% male); 59 (90%) were without previously diagnosed AF. AF lasting ≥6 minutes was detected in 18 of 59 subjects (31%) without previously diagnosed AF and in 5 of 7 subjects (71%) with a previous AF diagnosis. Among the 23 with detected AF, episodes were present on 16% of patient days. Although 14 of 23 patients (61%) had AF on <5% of monitored days, the average duration of AF episodes was <1 hour in 13 of 23 patients (52%). Among patients with AF ≥6 minutes, 19 of 23 (83%) had a CHA2DS2-VASc score ≥2. When investigating individual HD parameters, higher dialysate calcium (>2.5 vs. 2.5 mEq/l: incidence rate ratio = 0.62; 95% CI, 0.48-0.80) was associated with lower AF risk whereas higher dialysate bicarbonate concentrations (>35 vs. 35 mEq/l: incidence rate ratio = 3.18; 95% CI, 1.13-8.94) were associated with higher AF risk. CONCLUSION: New AF was detected in approximately one-third of patients with KF-HD. AF affects a substantial proportion of patient days and may be an underappreciated cause of stroke in KF-HD.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Koplan BA, Winkelmayer WC, Costea AI, et al. Implantable Loop Recorder Monitoring and the Incidence of Previously Unrecognized Atrial Fibrillation in Patients on Hemodialysis. Kidney Int Rep. 2021. PMID: 35155858. doi:10.1016/j.ekir.2021.10.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。